FDA Investigator Devon O Seymour
Devon O Seymour has inspections in 1 countries as of 11 Jan 2024. Devon O Seymour has collaborated with a combined 1488 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
45
Last Inspection Date:
11 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Albert Thompson,
Amber D Brodas,
Amy Kim,
Amy R Glynn,
Amy W Yan Mai,
Andrew Cohen,
Andrew F Cohen,
Andrew J Garufi,
Andrew J Seaborn,
Ashley Defilippis,
Ashley Polizzotto,
Betty M Ng Lee,
Brandon J Kocurek,
Carr Sharpe,
Charisse K Green,
Christian Parra,
Christopher M Jenner,
Christopher S Fields,
Cristina E Mosquera,
Daniel E Needham,
Debra D Devlieger,
Donald J Ullstrom,
Donald Ullstrom,
Duo D Chen,
Edouard Viard,
Emilio Z Azukwu,
Eric J Reisenauer,
Erica B Raphael,
Erik D Sandvig,
Eufemia G Gonzalez,
Felix Maldonado,
Gerard D Difiore,
Gray,
Greg W Hites,
Jackson Y See,
Jana J Lau,
Joshua D Lopez,
Joy A Matthias,
Joy P Matthias,
Joyce A Williams,
Judy C Nepsa,
Juliana Falla,
Kevin A Gonzalez,
Kristen C Jackson,
Kristen M Campbell,
Kwong P Lee,
Laura A Munsterman,
Leroy Terrelonge,
LTJG Matthew R Palo,
Manhar Patel,
Manhar R Patel,
Melinee C Minhas,
Melissa N Gregorio,
Meredith P Soehl, Investigator,
Michael J Chan,
Michael R Dominick,
Milan S Mcgorty,
Morgan J Matthews,
Nicole Vaught,
Onieka T Carpenter,
Patrick R Dimapindan,
Patty P Kaewussdangkul,
Perez,
Peter M Trunk,
Peter R Caparelli,
Raymond M Lam,
Robert C Howard,
Robert E Moncayo,
Samuel A Francis,
Sarah A Meehan,
Satheesh Thomas,
Seemay A Lee,
Shantel S Brown,
Shantel S Tobias,
Shelly A Persaud,
Shreya Shah,
Sony Mathews,
State Agency,
Tania K Mercado,
Tracy M Portelli,
Vaishali J Patel,
Valerie A Potopsingh,
Victoria C Yang,
Wayne J Meyer,
Willy A Orantes,
Yuyan Liang,
Yvonne M Santiago,
Zameer Farouk
Devon O Seymour's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2023 | FDA 483 | TBN Labs, LLC. - Form 483, 2023-03-23 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more